Merit Medical Systems Inc income statement

In fiscal 2025, Merit Medical Systems Inc reported revenue of $1.52bn, up 11.8% on the year before, operating income of $185m (a 12.2% margin) and net income of $128m, or $2.13 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Merit Medical Systems Inc: income statement, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2011Dec 2011	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMSept 2026
Revenue	257	297	359	604	728	883	995	964	1,075	1,151	1,257	1,357	1,516	1,611
Cost of revenue	—	—	—	339	402	488	562	563	589	632	673	713	778	815
Gross profit	109	128	165	265	326	395	432	401	485	519	584	643	738	796
Research and development	11	15	22	45	51	60	66	58	71	76	83	87	97	97
Selling, general and administrative	65	88	105	184	229	276	327	298	336	343	374	400	455	482
Operating income	33	17	33	35	33	59	15	−2	61	88	124	156	185	218
Interest expense	0	1	1	9	8	10	12	10	5	6	16	31	26	32
Provision for credit losses	—	—	—	—	—	—	—	0	−1	0	0	1	1	1
Income before tax	33	17	33	25	36	50	2	−13	54	83	112	150	171	212
Income tax	11	4	10	5	8	8	−3	−3	5	8	18	30	42	52
Net income	23	12	23	20	28	42	5	−10	48	75	94	120	128	160
Diluted EPS	$0.63	$0.35	$0.58	$0.45	$0.55	$0.78	$0.10	−$0.18	$0.84	$1.29	$1.62	$2.03	$2.13	$2.66
Diluted shares (average)	36m	36m	40m	45m	50m	54m	56m	55m	57m	58m	58m	59m	60m	60m
EBITDA	45	32	52	79	87	128	108	93	145	169	214	258	308	342

US$ millions unless shown otherwise. Fiscal quarters.

Merit Medical Systems Inc: income statement, quarterly
Quarter	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026	2026 Q3Sept 2026
Revenue	355	355	382	384	394	382	419	416
Cost of revenue	182	183	198	198	199	197	204	216
Gross profit	173	172	184	186	195	185	215	201
Research and development	25	22	24	24	27	23	25	22
Selling, general and administrative	111	107	113	120	115	118	129	120
Operating income	37	41	47	43	54	44	60	59
Interest expense	8	7	7	7	6	7	12	7
Provision for credit losses	−0	0	1	0	0	−0	1	0
Income before tax	33	38	43	39	51	54	51	56
Income tax	5	8	11	11	13	13	13	13
Net income	28	30	33	28	38	41	39	42
Diluted EPS	$0.46	$0.49	$0.54	$0.46	$0.64	$0.68	$0.65	$0.70
EBITDA	65	70	78	74	86	75	91	91

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: IART vs MMSI MMSI vs PEN ITGR vs MMSI HAE vs MMSI

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Merit Medical Systems Inc's SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Merit Medical Systems Inc.